ZEISS grants license for LED fluorescence excitation to Lumencor, Inc.

JENA/Germany, Beaverton/USA, (PresseBox) - ZEISS has granted a license for patents relating to LED fluorescence excitation in microscopy to Lumencor, Inc., Beaverton, USA. These patents protect the use of light emitting diodes for the excitation of fluorescence radiation in light microscopes. The property rights, which are valid in the USA and Canada, were acquired by ZEISS in 2005.

ZEISS uses this technology in a number of products such as iLED-module, Axio Scope with integrated LED illumination for fluorescence applications and Colibri.2 for a wide range of applications extending from routine to high-end microscopy. The users benefit from the optimum flexibility and maximum specimen protection offered by the LEDs as light sources for fluorescence excitation.

Lumencor is based in Oregon, USA where it develops and manufactures pre-configured, custom and OEM lighting solutions for scientists, researchers, medical device manufacturers, and scientific instrument manufacturers. Lumencor utilizes LEDs in combination with its own proprietary light sources and optical systems to create innovative solid-state lighting systems for imaging and analysis. Lumencor creates solutions for a wide range of applications, including microarrays, microfluidics, sequencing, high content screening, optogenetics, digital pathology, immunochemistry, clinical chemistry, and endoscopy, in addition to fluorescence microscopy. Lumencor illumination and imaging products are designed as superior replacements for conventional light sources, and also provide a feature-rich platform for the development of advanced imaging and analysis systems.

Press releases you might also be interested in

Subscribe for news

The subscribtion service of the PresseBox informs you about press information of a certain topic by your choice at a choosen time. Please enter your email address to receive the email with the press releases.

An error occurred!

Thank you! You will receive a confirmation email within a few minutes.


I want to subscribe to the gratis press mail and have read and accepted the conditions.